Skip to main content
. 2020 Jun 8;42(7):1610–1620. doi: 10.1002/hed.26320

TABLE 3.

Distribution of cases according to the pathology treated in PANDEMIC‐group and CONTROL‐group

Pathologies treated PANDEMIC‐group (Feb‐Apr, 2020) CONTROL‐group (Feb‐Apr, 2019)
Benign tumors 5 (20.8%) 12 (19.7%)
Cerebrospinal fluid leak 2 (8.3%) 2 (3.3%)
Epistaxis 2 (8.3%) 3 (4.9%)
Functional diseases 1 (4.2%) 5 (8.2%)
Inflammatory diseases 3 (12.5%) 28 (45.9%)
Malignant tumors 11 (45.8%) 11 (18.0%)
Total 24 (100.0%) 61 (100.0%)